Explore drug information in your own words.
Type a question in the search bar above to get started. Each question is answered independently.
AI can make mistakes. Verify answers against the original sources before relying on them.
| Stem definition | Drug id | CAS RN |
|---|---|---|
| atropine derivatives | 4660 | 31610-87-4 |
| Dose | Unit | Route |
|---|---|---|
| 3 | mg | O |
None
| Property | Description | Value | Unit | Confidence | Similarity |
|---|---|---|---|---|---|
| azlogd74 | LogD at pH 7.4 | -1.708 | High | 0.80 | |
| caco2-efflux | Caco-2 efflux ratio (BA/AB) | 0.538 | High | 0.80 | |
| caco2-intrinsic-papp | Caco-2 intrinsic apparent permeability | 0.397 | 10^-6 cm/s | High | 0.80 |
| dh-clint | Dog hepatocyte intrinsic clearance | 3.793 | uL/min/10^6 cells | High | 0.80 |
| dppb | Dog plasma protein binding (% unbound) | 88.540 | % | High | 0.80 |
| fcs-ppb | Fetal calf serum protein binding (% unbound) | 48.560 | % | High | 0.80 |
| herg | hERG pIC50 | 4.393 | pIC50 | High | 0.80 |
| hh-clint | Human hepatocyte intrinsic clearance | 1.928 | uL/min/10^6 cells | High | 0.80 |
| hlm-clint | Human liver microsomal intrinsic clearance | 3.327 | uL/min/mg protein | High | 0.80 |
| hppb | Human plasma protein binding (% unbound) | 76.180 | % | High | 0.80 |
| kinase-safety-class | ACVR2B,AXL,BRAF,BTK,CAMK2D,CDK5,CDK9,EIF2AK3,EPHB4,ERBB2,GRK2,ITK,MAPK7,NTRK2,PDK1,PDK4,PRKDC,TEK,TGFBR1 | 19 | |||
| kinase-selectivity-class | EIF2AK3 | 1 | |||
| mdck-mdr1-bcrp-efflux | MDCK-MDR1-BCRP efflux ratio | 0.527 | Moderate | 0.70 | |
| mdck-mdr1-efflux | MDCK-MDR1 efflux ratio | 0.447 | High | 0.80 | |
| mh-clint | Mouse hepatocyte intrinsic clearance | 29.580 | High | 0.80 | |
| mppb | Mouse plasma protein binding (% unbound) | 86.320 | High | 0.80 | |
| nih-mdck-mdr1-efflux | NIH MDCK-MDR1 efflux ratio | 0.507 | High | 0.80 | |
| pfas-class | PFAS structural alert (1 = True, 0 = False) | 0 | |||
| pld-class | Phospholipidosis risk class (1 = positive, 0 = negative) | 1 | High | 0.80 | |
| pppb | Pig plasma protein binding (% unbound) | 77.970 | % | High | 0.80 |
| rat-kpuu-brain | Rat brain Kpuu | 0.003 | % | Moderate | 0.70 |
| rh-clint | Rat hepatocyte intrinsic clearance | 15.668 | uL/min/10^6 cells | High | 0.80 |
| rh-fuinc | Rat hepatocyte fraction unbound in incubation | 90.400 | % | High | 0.80 |
| rppb | Rat plasma protein binding (% unbound) | 74.950 | % | High | 0.80 |
| solubility-dd | Solubility at pH 7.4 in DMSO | 833.681 | uM | High | 0.80 |
None
None
None
None
None
| Source | Code | Description |
|---|---|---|
| ATC | A03BB02 | ALIMENTARY TRACT AND METABOLISM DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS BELLADONNA AND DERIVATIVES, PLAIN Belladonna alkaloids, semisynthetic, quaternary ammonium compounds |
| MeSH PA | D010276 | Parasympatholytics |
| MeSH PA | D018373 | Peripheral Nervous System Agents |
None
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 13.24 | acidic |
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Muscarinic acetylcholine receptor M2 | GPCR | Kd | 8.57 | CHEMBL | |||||
| Muscarinic acetylcholine receptor M1 | GPCR | Kd | 8.60 | CHEMBL | |||||
| Muscarinic acetylcholine receptor M3 | GPCR | Kd | 8.59 | CHEMBL | |||||
| Muscarinic acetylcholine receptor DM1 | GPCR | Ki | 8.62 | CHEMBL |
| ID | Source |
|---|---|
| D01077 | KEGG_DRUG |
| 4018467 | VANDF |
| CHEBI:134749 | CHEBI |
| CHEMBL1187724 | ChEMBL_ID |
| CHEMBL516476 | ChEMBL_ID |
| CHEMBL2146143 | ChEMBL_ID |
| C006649 | MESH_SUPPLEMENTAL_RECORD_UI |
| 52-88-0 | SECONDARY_CAS_RN |
| DB13833 | DRUGBANK_ID |
| 001716 | NDDF |
| 006113 | NDDF |
| 391795000 | SNOMEDCT_US |
| C0066332 | UMLSCUI |
| 656598 | PUBCHEM_CID |
| 436 | INN_ID |
| 80719I460H | UNII |
None